Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2280]

Examining NSCLC responses to durvalumab monotherapy

Brandon Higgs - MedImmune, Gaithersburg, USA

Examining NSCLC responses to durvalumab monotherapy ( Brandon Higgs - MedImmune, Gaithersburg, USA )

PD-L2 expression and its relevance to anti-PD-1 therapy in cancer

Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA

PD-L2 expression and its relevance to anti-PD-1 therapy in cancer ( Dr Jennifer Yearley - Merck Research Labs, Biologics Discovery, Palo Alto, USA )

Prostate highlights from ECC 2015

Prof Noel Clarke and Dr Bertrand Tombal

Prostate highlights from ECC 2015 ( Prof Noel Clarke and Dr Bertrand Tombal )

NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs

Prof Philippe Ruszniewski - Paris Diderot University, Paris, France

NETTER-1: Targeted radionuclide therapy improves PFS in mid-gut NETs ( Prof Philippe Ruszniewski - Paris Diderot University, Paris, France )

RADIANT-4: Results of international trial show promise in the treatment of...

Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA

RADIANT-4: Results of international trial show promise in the treatment of neuroendocrine tumours ( Prof James Yao - University of Texas MD Anderson Cancer Center, Houston, USA )

Tailoring treatment strategies in prostate cancer: expert insight

Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu

Tailoring treatment strategies in prostate cancer: expert insight ( Prof Eleni Efstathiou, Dr Maria De Santis, Dr Nina Tunariu )

Circulating levels of tumour DNA in plasma may help monitor treatment response...

Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia

Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL ( Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia )

Cytogenetic and proteomic prognostic markers of CLL

Dr Lauren Thurgood - Flinders University, Adelaide, South Australia

Cytogenetic and proteomic prognostic markers of CLL ( Dr Lauren Thurgood - Flinders University, Adelaide, South Australia )

Predicting progression and survival in CLL

Prof Jonathan Strefford - University of Southampton, Southampton, UK

Predicting progression and survival in CLL ( Prof Jonathan Strefford - University of Southampton, Southampton, UK )

Expert panel discussion: The best of iwCLL 2015

Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai

Expert panel discussion: The best of iwCLL 2015 ( Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai )

Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells

Dr Alexey Danilov - Oregon Health and Science University, Portland, USA

Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells ( Dr Alexey Danilov - Oregon Health and Science University, Portland, USA )

High remission rates for new CLL treatment

Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia

High remission rates for new CLL treatment ( Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia )

More from ecancer